Literature DB >> 9930302

Liposomes enhance delivery and expression of an RGD-oligolysine gene transfer vector in human tracheal cells.

M Colin1, R P Harbottle, A Knight, M Kornprobst, R G Cooper, A D Miller, G Trugnan, J Capeau, C Coutelle, M C Brahimi-Horn.   

Abstract

Nonviral gene delivery systems consist predominantly of lipoplexes or receptor-targeting and nontargeting polyplexes. We examined integrin-mediated gene delivery using an Arg-Gly-Asp/oligo-L-lysine ([K]16RGD) cyclic peptide and investigated its gene transfer efficiency when associated with a cationic liposome. We demonstrated that human cystic fibrosis and noncystic fibrosis tracheal epithelial cells in culture express integrins that recognise the RGD integrin-binding motif. We found a 10-fold (P < 0.01) increased expression of a luciferase encoding plasmid in these cells when complexing the plasmid to the [K]16RGD peptide as compared with plasmid alone. This increase was specific to the [K]16RGD peptide since neither a [K]16RGE nor a [K]16 peptide gave a comparable increase. Expression was further enhanced 30-fold (P < 0.01) with lipofectamine and the ratio of DNA/peptide/lipofectamine was critical for specificity and expression. Fluorescence and radioactive labelling of the complex showed that the [K]16RGD peptide increased the endocytic uptake of DNA into cells. The cell association of both DNA and peptide increased even further with lipofectamine. Confocal microscopy showed that the [K]16RGD peptide and the DNA internalised together within 30 min and localised to vesicles in the perinuclear region. These results show that an integrin-binding ligand can deliver genetic material to airway cells and that a cationic liposome can enhance the efficacy of this nonviral vector system.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9930302     DOI: 10.1038/sj.gt.3300760

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  7 in total

Review 1.  The nuclear pore complex: the gateway to successful nonviral gene delivery.

Authors:  Marieke A E M van der Aa; Enrico Mastrobattista; Ronald S Oosting; Wim E Hennink; Gerben A Koning; Daan J A Crommelin
Journal:  Pharm Res       Date:  2006-03-15       Impact factor: 4.200

2.  Gene delivery to differentiated neurotypic cells with RGD and HIV Tat peptide functionalized polymeric nanoparticles.

Authors:  Jung Soo Suk; Junghae Suh; Kokleong Choy; Samuel K Lai; Jie Fu; Justin Hanes
Journal:  Biomaterials       Date:  2006-10       Impact factor: 12.479

3.  Cyclic RGD-targeting of reversibly stabilized DNA nanoparticles enhances cell uptake and transfection in vitro.

Authors:  Qing-Hui Zhou; Ye-Zi You; Chao Wu; Yi Huang; David Oupický
Journal:  J Drug Target       Date:  2009-06       Impact factor: 5.121

Review 4.  Non-invasive assessment of vessel morphology and function in tumors by magnetic resonance imaging.

Authors:  Fabian Kiessling; Manfred Jugold; Eva C Woenne; Gunnar Brix
Journal:  Eur Radiol       Date:  2007-02-17       Impact factor: 7.034

5.  Integrin targeted delivery of gene therapeutics.

Authors:  Rudy L Juliano; Xin Ming; Osamu Nakagawa; Rongzuo Xu; Hoon Yoo
Journal:  Theranostics       Date:  2011-03-02       Impact factor: 11.556

6.  Development of lipopolyplexes for gene delivery: A comparison of the effects of differing modes of targeting peptide display on the structure and transfection activities of lipopolyplexes.

Authors:  Robin Bofinger; May Zaw-Thin; Nicholas J Mitchell; P Stephen Patrick; Cassandra Stowe; Ana Gomez-Ramirez; Helen C Hailes; Tammy L Kalber; Alethea B Tabor
Journal:  J Pept Sci       Date:  2018-10-16       Impact factor: 1.905

7.  Synthesis and characterization of nanoscale dendritic RGD clusters for potential applications in tissue engineering and drug delivery.

Authors:  Hu Yang; Weiyuan John Kao
Journal:  Int J Nanomedicine       Date:  2007
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.